Project Details
| Status | Active |
|---|---|
| Effective start/end date | 9/9/19 → 9/9/24 |
Funding
- ICON Clinical Research, LLC (Prot#RPC01-3201)
- Celgene International II Sàrl (Prot#RPC01-3201)
Prot#RPC01-3201: INDUCTION STUDY #1- A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Cro
- Hanauer, stephen B (PD/PI)
Project: Research project